Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Mavroudis D, Pavlakou G, Blazoyiannakis G, Veslemes M, Apostolopoulou F, Kouroussis Ch, Kakolyris S, Agelaki S, Androulakis N, Vardakis N, Magkanas E, Samonis G, Georgoulias V. Mavroudis D, et al. Among authors: agelaki s. Lung Cancer. 2003 Jan;39(1):71-6. doi: 10.1016/s0169-5002(02)00307-0. Lung Cancer. 2003. PMID: 12499097 Clinical Trial.
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
Pallis AG, Agelidou A, Papakotoulas P, Tsaroucha A, Agelidou M, Agelaki S, Androulakis N, Vamvakas L, Gerogianni A, Kotsakis A, Kentepozidis N, Georgoulias V. Pallis AG, et al. Among authors: agelaki s. Lung Cancer. 2006 May;52(2):165-71. doi: 10.1016/j.lungcan.2006.01.005. Epub 2006 Mar 24. Lung Cancer. 2006. PMID: 16563559 Clinical Trial.
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
Kakolyris S, Samonis G, Koukourakis M, Vlachonicolis I, Chalkiadakis G, Kalbakis K, Souglakos I, Agelaki S, Toloudis P, Georgoulias V. Kakolyris S, et al. Among authors: agelaki s. Am J Clin Oncol. 1998 Oct;21(5):505-8. doi: 10.1097/00000421-199810000-00018. Am J Clin Oncol. 1998. PMID: 9781610 Clinical Trial.
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Kakolyris S, Souglakos J, Agelaki S, Kourousis CH, Mavroudis D, Sarra E, Malliotakis P, Georgoulias V. Kakolyris S, et al. Among authors: agelaki s. Lung Cancer. 2000 Dec;30(3):193-8. doi: 10.1016/s0169-5002(00)00146-x. Lung Cancer. 2000. PMID: 11137204 Clinical Trial.
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C, Agelaki S, Mavroudis D, Souglakos J, Kakolyris S, Kalbakis K, Vardakis N, Reppa D, Hatzidaki D, Samonis G, Georgoulias V. Kouroussis C, et al. Among authors: agelaki s. Cancer Chemother Pharmacol. 2000;46(6):488-92. doi: 10.1007/s002800000184. Cancer Chemother Pharmacol. 2000. PMID: 11138462 Clinical Trial.
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V; Greek Cooperative Group for Lung Cancer. Kakolyris S, et al. Among authors: agelaki s. Lung Cancer. 2001 May;32(2):179-87. doi: 10.1016/s0169-5002(00)00212-9. Lung Cancer. 2001. PMID: 11325489 Clinical Trial.
168 results